YAP1 and chronic myelogenous leukemia, BCR-ABL1 positive: EGFR silencing (Fig. 6e) almost completely reversed YAP1 nuclear translocation (Fig. 6f), KRAS activation, and ERK 1/2 phosphorylation (Supplementary Fig. S3A-B) induced by CML.